연구동향 분석

클로자핀을 복용중인 조현병 환자의 변비에 영향을 미치는 임상 요인

이민주 김성진 문정준 전동욱 정도운 2022년

논문상세정보
인용/피인용
' 클로자핀을 복용중인 조현병 환자의 변비에 영향을 미치는 임상 요인' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Cholinergic antagonists
  • clozapine
  • constipation
  • drug monitoring
  • schizophrenia.
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
240 0

0.0%

' 클로자핀을 복용중인 조현병 환자의 변비에 영향을 미치는 임상 요인' 의 참고문헌

  • 정신분열병 및 기타 정신증적 장애로 일 종합병원에 입원한 환자의 치료에서 Clozapine의 사용의 실태 : 유효성 및 부작용
    김찬우 [2003]
  • first-and second-generation antipsychotics in treatment-refractory schizophrenia : systematic review and meta-analysis
    Siskind D [2016]
  • The significance of sampling time in therapeutic drug monitoring of clozapine
    Jakobsen M [2017]
  • The role of M1 muscarinic receptor agonism of Ndesmethylclozapine in the unique clinical effects of clozapine
    Weiner DM [2004]
  • The anticholinergic drug scale as a measure of drug-related anticholinergic burden : associations with serum anticholinergic activity
    Carnahan RM [2006]
  • Serum antimuscarinic activity during clozapine treatment
    de Leon J [2003]
  • Risk factors for ileus in patients with schizophrenia
    Nielsen J [2012]
  • Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine or risperidone
    Tracy JI [1998]
  • Prevalence and factors associated with clozapine-related constipation : an observational study
    Chougule A [2018]
  • Prevalence and Predictors of Clozapine-Associated Constipation : a Systematic Review and Meta-Analysis
    Shirazi A [2016]
  • Population Pharmacokinetics of Clozapine : a Systematic Review
    Albitar O [2020]
  • Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
    De Hert M [2011]
  • Pharmacology of N-desmethylclozapine
    Lameh J [2007]
  • Patterns of Antipsychotic Prescription to Patients with Schizophrenia in Korea: Results from the Health Insurance Review & Assessment Service-National Patient Sample
    박선철 [2014]
  • Pain insensitivity in schizophrenic patients. A surgical dilemma
  • Management of the adverse effects of clozapine
    Young CR [1998]
  • Interrater reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale measured in patients treated with clozapine
    Ohlsen R [2008]
  • International consensus study of antipsychotic dosing
    Gardner DM [2010]
  • Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients
  • Improved efficacy and fewer side effects under clozapine treatment after addition of fluvoxamine
    Szegedi A [1995]
  • Genetic and Clinical Factors Affecting Plasma Clozapine Concentration
    Olsson E [2015]
  • Factors predicting use of laxatives in outpatients stabilized on clozapine
    Bailey L [2015]
  • Decreased pain sensitivity among people with schizophrenia : a meta-analysis of experimental pain induction studies
    Stubbs B [2015]
  • Constipation screening in people taking clozapine : a diagnostic accuracy study
  • Cognitive burden of anticholinergic medications in psychotic disorders
    Eum S [2017]
  • Clozapine-treated patients have marked gastrointestinal hypomotility, the probable basis of life-threatening gastrointestinal complications: a cross sectional study
  • Clozapine-induced agranulocytosis--incidence and risk factors in the United States
    Alvir JMJ [1993]
  • Clozapine safety, 40 years later
    Raja M [2014]
  • Clozapine induced gastrointestinal hypomotility: a potentially life threatening adverse event. A review of the literature
    West S [2017]
  • Clozapine and metabolites : concentrations in serum and clinical findings during treatment of chronically psychotic patients
  • Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists
  • Augmentation of clozapine with a second antipsychotic-a meta-analysis
    Taylor DM [2012]
  • Antipsychotics for acute and chronic pain in adults
    Seidel S [2008]
  • Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine
  • Agonist activity of N-desmethylclozapine at δ-opioid receptors of human frontal cortex
    Olianas MC [2009]
  • Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances
    Lu ML [2004]
  • A population-based study on bowel habits in a Korean community : prevalence of functional constipation and self-reported constipation
    Jun DW [2006]